Epidemiologic Survey of Lower Urinary Tract Symptoms in Asia and Australia Using the International Prostate Symptom Score
Version of Record online: 1 JUL 2007
International Journal of Urology
Volume 4, Issue 1, pages 40–46, January 1997
How to Cite
Homma, Y., Kawabe, K., Tsukamoto, T., Yamanaka, H., Okada, K., Okajima, E., Yoshida, O., Kumazawa, J., Fang-Liu, G., Lee, C., Hsu, T.-C., Cruz, R. C. d., Tantiwang, A., Lim, P. H., Sheikh, M. A., Bapat, S. D., Marshall, V. R., Tajima, K. and Aso, Y. (1997), Epidemiologic Survey of Lower Urinary Tract Symptoms in Asia and Australia Using the International Prostate Symptom Score. International Journal of Urology, 4: 40–46. doi: 10.1111/j.1442-2042.1997.tb00138.x
- Issue online: 1 JUL 2007
- Version of Record online: 1 JUL 2007
- Received Apr. 23, 1996; accepted for publication in revised form Jul. 22, 1996.
- lower urinary tract symptoms;
- benign prostatic hyperplasia
Background The prevalence of lower urinary tract symptoms was determined by survey as an initial step in estimating the significance of benign prostatic hyperplasia (BPH) in Asia and Australia.
Methods The symptom index (0 to 35) and quality-of-life (QOL) index (0 to 6) of the international prostate symptom score were measured in 7588 men in 9 Asian countries and 146 men in Australia.
Results The percentages of Asian men considered to be symptomatic (symptom index ≧ 8) were 18%, 29%, 40%, and 56% in the age groups of 40 to 49, 50 to 59, 60 to 69, and 70 to 79 years, respectively. For Australian men, these figures were 36%, 33%, and 37% in the 50 to 59, 60 to 69, and 70 to 79 year age groups, respectively.
Conclusions Our estimates indicate that the prevalences of symptomatic men in Asia and Australia are similar to or greater than those in Europe and America, and suggest BPH is similarly common in these areas.